Markus Friedrich

670 total citations
14 papers, 331 citations indexed

About

Markus Friedrich is a scholar working on Immunology, Dermatology and Epidemiology. According to data from OpenAlex, Markus Friedrich has authored 14 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Dermatology and 4 papers in Epidemiology. Recurrent topics in Markus Friedrich's work include Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Markus Friedrich is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Markus Friedrich collaborates with scholars based in Germany, United States and Switzerland. Markus Friedrich's co-authors include Wolfram Sterry, Khusru Asadullah, Hans‐Dieter Volk, Wolf‐Dietrich Döcke, Robert Sabat, Heike Audring, Sandra Philipp, J. Marcus Muche, Ansgar Lukowsky and Conny Höflich and has published in prestigious journals such as Blood, Journal of Investigative Dermatology and Journal of Leukocyte Biology.

In The Last Decade

Markus Friedrich

13 papers receiving 316 citations

Peers

Markus Friedrich
A. Howland Hartley United States
Markus Friedrich
Citations per year, relative to Markus Friedrich Markus Friedrich (= 1×) peers A. Howland Hartley

Countries citing papers authored by Markus Friedrich

Since Specialization
Citations

This map shows the geographic impact of Markus Friedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Friedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Friedrich more than expected).

Fields of papers citing papers by Markus Friedrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Friedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Friedrich. The network helps show where Markus Friedrich may publish in the future.

Co-authorship network of co-authors of Markus Friedrich

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Friedrich. A scholar is included among the top collaborators of Markus Friedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Friedrich. Markus Friedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wolk, Kerstin, Dagmar Wilsmann‐Theis, Nessr Abu Rached, et al.. (2025). Determinants of Satisfaction with Medical Care for Hidradenitis Suppurativa: Results from a Multicentre Survey in Germany. Dermatology and Therapy. 15(12). 3651–3670.
2.
Friedrich, Markus, Susanna Prösch, Conny Höflich, et al.. (2011). Persistent CMV infection correlates with disease activity and dominates the phenotype of peripheral CD8+ T cells in psoriasis. Experimental Dermatology. 20(7). 561–567. 16 indexed citations
3.
Döcke, Wolf‐Dietrich, Khusru Asadullah, Conny Höflich, et al.. (2008). Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis. Journal of Leukocyte Biology. 85(3). 582–593. 33 indexed citations
4.
Asadullah, Khusru, Robert Sabat, Markus Friedrich, Hans‐Dieter Volk, & Wolfram Sterry. (2004). Interleukin-10: An Important Immunoregulatory Cytokine With Major Impact on Psoriasis. Current Drug Targets - Inflammation & Allergy. 3(2). 185–192. 63 indexed citations
5.
Friedrich, Markus, Wolfram Sterry, & Khusru Asadullah. (2003). Neue Entwicklungen in der systemischen Psoriasistherapie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 1(1). 12–21. 5 indexed citations
6.
Boehncke, Wolf‐­Henning, Markus Friedrich, Ulrich Mrowietz, et al.. (2003). Stellenwert von Biologics in der Psoriasis‐Therapie: Ein Konsensus‐Papier der Arbeitsgruppe Psoriasis, Arbeitsgemeinschaft dermatologische Forschung. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 1(8). 620–628. 7 indexed citations
7.
Friedrich, Markus, Wolf‐Dietrich Döcke, Sandra Philipp, et al.. (2002). Immunomodulation by Interleukin-10 Therapy Decreases the Incidence of Relapse and Prolongs the Relapse-free Interval in Psoriasis. Journal of Investigative Dermatology. 118(4). 672–677. 66 indexed citations
8.
Asadullah, Khusru, Hans‐Dieter Volk, Markus Friedrich, & Wolfram Sterry. (2002). Experimental therapies for psoriasis.. PubMed. 50(6). 411–20. 5 indexed citations
9.
Asadullah, Khusru, Markus Friedrich, S. Hanneken, et al.. (2001). Effects of Systemic Interleukin-10 Therapy on Psoriatic Skin Lesions: Histologic, Immunohistologic, and Molecular Biology Findings. Journal of Investigative Dermatology. 116(5). 721–727. 63 indexed citations
10.
Friedrich, Markus, et al.. (2001). Addition of Pentoxifylline Could Reduce the Side Effects of Fumaric Acid Esters in the Treatment of Psoriasis. Acta Dermato Venereologica. 81(6). 429–430. 20 indexed citations
13.
Asadullah, Khusru, et al.. (1997). Granzyme A mRNA Expression in Mycosis Fungoides Progression. Blood. 90(9). 3810–3810. 4 indexed citations
14.
Asadullah, K., Markus Friedrich, Angela Siegling, et al.. (1996). IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is unlikely to be an autocrine growth factor in vivo. Archives of Dermatological Research. 289(1). 9–13. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026